BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 8, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2006
View Archived Issues
BIM-28125: new ghrelin agonist improves glucocorticosteroid catabolic effects
Read More
FG-3019 has multiple effects in pancreatic cancer models
Read More
Clearance sought for study of oral interferon alpha in IPF
Read More
Ricerca BioSciences, new development partner for PhytoMedical's BDC-03
Read More
Athenagen and Zapaq to merge
Read More
TAK-491 for hypertension enters phase II
Read More
Portola studies oral Factor Xa inhibitor in knee replacement surgery patients
Read More
Antiarrhythmic efficacy and tolerability of the dual potassium/sodium channel blocker RSD-1235
Read More
Neose updates NE-180 progress
Read More
Xencor completes bridge financing
Read More
Alfacell forms collaboration for next-generation targeted therapies for cancer
Read More
Procter & Gamble and ARYx form alliance for GI drug ATI-7505
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Curis and Genentech halt phase I basal cell carcinoma study
Read More
Phase I study of PhytoSel to lower side effects of chemotherapeutic drugs
Read More
EMEA clears Kamada's phase I plans for alpha-1 proteinase inhibitor
Read More
CB-7630 begins U.S. phase I study for advanced prostate cancer
Read More
Recent patents describe new therapeutic agents for diabetes
Read More
Eisai and Teva to end rasagiline collaboration agreement
Read More
Zhejiang University report on new antitumor agent targeted for cervical cancer
Read More
Banyu studies Gardasil in Japan
Read More
New possible treatments for metabolic disorders described in recent patents
Read More
Preclinical thrombolytic activity of HTU-PA shown in rat, hamster, rabbit and dog models
Read More
FDA approves Atripla, first once-daily single tablet regimen for HIV
Read More
Novel DHEA analogue shows antiarrhythmic potential without inducing QT prolongation
Read More
CJC-1295 normalizes body weight and length parameters in a mouse model of GH deficiency
Read More
